Клинико-морфологические особенности и иммунный профиль почечно-клеточных опухолей со светлой цитоплазмой

В структуре онкологической заболеваемости почечно-клеточная карцинома занимает 10 место среди злокачественных новообразований. Рост заболеваемости наблюдается с возраста в 35-40 лет и достигает максимума к 65-70 годам. Среди всех опухолей почки светлоклеточная почечно-клеточная карцинома по частоте встречаемости занимает первое место. Между тем, из-за высокой гетерогенности группы почечно-клеточных карцином со светлой цитоплазмой возникают существенные сложности как в морфологической верификации этих новообразований, так и в проведении дифференциальной диагностики. В статье представлена характеристика всех нозологических форм опухолей почки со светлой цитоплазмой, приведены наиболее полные данные по известным базам иммуногистохимических маркеров, адаптированным для каждой конкретной нозологической единицы. 

1. Ljungberg B., Campbell S.C., Choi H.Y. et al. The epidemiology of renal cell carcinoma. Eur Urol 2011;60(4):615–21. DOI: 10.1016/j.eururo.2011.06.049.

2. Ferlay J., Shin H.R., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127(12):2893–917. DOI: 10.1002/ijc.25516.

3. Ridge C.A., Pua B.B., Madoff D.C. Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol 2014;31(1): 3–8. DOI: 10.1055/s-0033-1363837.

4. Goyal R., Gersbach E., Yang X.J., Rohan S.M. Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine. Arch Pathol Lab Med 2013;137(4):467– 80. DOI: 10.5858/arpa.2012-0085-RA.

5. Ross H., Martignoni G., Argani P. Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 2012;136(4):391–9. DOI: 10.5858/arpa.2011-0479-RA.

6. Bai X., Wu C.L. Renal cell carcinoma and mimics: pathologic primer for radiologists. AJR Am J Roentgenol 2012;198(6): 1289–93. DOI: 10.2214/AJR.12.8586.

7. Reuter V.E., Tickoo S.K. Adult renal tumors. In: Sternberg’s Diagnostic Surgical Pathology. Vol. 2. 5th edn. Eds.: S.E. Mills, D. Carter, J.K. Greenson et al. Philadelphia, PA: Lippincott Williams & Wilkins, 2010. Pp. 1758–1798.

8. Storkel S., Eble J.N., Adlakha K. et al. Classification of renal cell carcinoma: Workgroup No. 1, Union Internationale Contrele Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80(5):987–9.

9. MacLennan G.T., Cheng L. Neoplasms of the kidney. In: Urologic Surgical Pathology. 2nd edn. Eds.: D.G. Bostwik, L. Cheng. London, United Kingdom: Mosby Elsevier, 2008. Pp. 77–171.

10. Amin M.B., Tamboli P., Javidan J. et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002;26(3):281–91.

11. Ning L., Weidong G., Feng Q. et al. Does the Fuhrman or World Health Organization/ International Society of Urological Pathology grading system apply to the Xp11.2 translocation renal cell carcinoma? Am J Pathol 2018;188(4):929–36. DOI: 10.1016/j.ajpath.2017.12.018.

12. de Peralta-Venturina M., Moch H., Amin M. et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 2001;25(3):275–84.

13. Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6(7):655–63.

14. Verine J., Colin D., Nheb M. et al. Architectural patterns are a relevant morphologic grading system for clear cell renal cell carcinoma prognosis assessment. Am J Surg Pathol 2018;42(4):423–41. DOI: 10.1097/PAS.0000000000001025.

15. Al-Ahmadie H.A., Alden D., Fine S.W. et al. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study. Am J Surg Pathol 2011;35(7): 949–61. DOI: 10.1097/PAS.0b013e31821e25cd.

16. Wykoff C.C., Beasley N.J., Watson P.H. et al. Hypoxia-inducible expression of tumorassociated carbonic anhydrases. Cancer Res 2000;60(24):7075–83.

17. Goyal R., Zhu B., Parimi V. et al. Immunohistochemical (IHC) expression of carbonic anhydrase IX (CA9) in papillary (PRCC) and chromophobe (CHRCC) renal cell carcinoma is associated with necrosis. Mod Pathol 2011;24(1S):194A.

18. Goyal R., Gersbach E., Yang X.J., Rohan S.M. Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine. Arch Pathol Lab Med 2013;137(4):467–80; DOI: 10.5858/arpa.2012-0085-RA.

19. Mancilla-Jimenez R., Stanley R.J., Blath R.A. Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 1976;38(6):2469–80.

20. Delahunt B., Eble J.N., McCredie M.R. et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001;32(6):590–5. DOI: 10.1053/hupa.2001.24984.

21. Tretiakova M.S., Sahoo S., Takahashi M. et al. Expression of alphamethylacyl-CoA racemase in papillary renal cell carcinoma. Am J SurgPathol 2004;28(1):69–76.

22. Skinnider B.F., Folpe A.L., Hennigar R.A. et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005;29(6):747–54.

23. Kuroda N., Kanomata N., Yamaguchi T. et al. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma. Med Mol Morphol 2011;44(2):111–5. DOI: 10.1007/s00795009-0461-z.

24. Amin M.B., Paner G.P., Alvarado-Cabrero I. et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol 2008;32(12):1822–34. DOI: 10.1097/PAS.0b013e3181831e68.

25. Przybycin C.G., Cronin A.M., Darvishian F. et al. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution. Am J Surg Pathol 2011;35(7):962–70. DOI: 10.1097/PAS.0b013e31821a455d.

26. Abrahams N.A., MacLennan G.T., Khoury J.D. et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004;45(6):593–602. DOI: 10.1111/j.1365-2559.2004.02003.x.

27. Nagy A., Zoubakov D., Stupar Z., Kovacs G. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma. Int J Cancer 2004;109(3):472–5. DOI: 10.1002/ijc.11694.

28. Rohan S.M., Xiao Y., Liang Y. et al. Clearcell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel–Lindau gene and hypoxia-inducible factor pathwayrelated proteins. Mod Pathol 2011;24(9):1207–20. DOI: 10.1038/modpathol.2011.80.

29. Kuroda N., Ohe C., Kawakami F. et al. Clear cell papillary renal cell carcinoma: a review. Int J Clin Exp Pathol 2014;7(11):7312–8.

30. Gobbo S., Eble J.N., Grignon D.J. et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008;32(8):1239–45. DOI: 10.1097/PAS.0b013e318164bcbb.

31. Suzigan S., López-Beltrán A., Montironi R. et al. Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol 2006;125(2):217–22. DOI: 10.1309/AH6F-C77P-YR2V-6YAY.

32. Srigley J.R., Delahunt B., Eble J.N. et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol 2013;37(10):1469–89. DOI: 10.1097/PAS.0b013e318299f2d1.

33. Hindman N.M., Bosniak M.A., Rosenkrantz A.B. et al. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings. AJR Am J Roentgenol 2012;198(1):W20–6. DOI: 10.2214/AJR.11.6762.

34. Williamson S.R., Halat S., Eble J.N. et al. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 2012;36(10):1425–33. DOI: 10.1097/PAS.0b013e31825b37f0.

35. Sun B.L., Abern M., Garzon S. et al. Cystic nephroma/mixed epithelial stromal tumor: a benign neoplasm with potential for recurrence. Int J Surg Pathol 2015;23(3):238–42. DOI: 10.1177/1066896914563391.

36. Smith S.C., Trpkov K., Chen Y.B. et al. Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol 2016;40(11):1457–72. DOI: 10.1097/PAS.0000000000000719.

37. Indraneel B., Sher S.Y., Vinay T. et al. Tubulocystic renal cell carcinoma: a great imitator. Rev Urol 2016;18(2):118–21. DOI: 10.3909/riu0692.

38. Skinnider B.F., Folpe A.L., Hennigar R.A. et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J SurgPathol 2005;29(6):747–54.

39. Argani P., Antonescu C.R., Illei P.B. et al. Primary renal neoplasms with the ASPLTFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001;159(1):179–92. DOI: 10.1016/S0002-9440(10)61684-7.

40. Argani P., Olgac S., Tickoo S.K. et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007;31(8):1149–60. DOI: 10.1097/PAS.0b013e318031ffff.

41. Davis I.J., Hsi B.L., Arroyo J.D. et al. Cloning of an alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA 2003;100(10):6051–6. DOI: 10.1073/pnas.0931430100.

42. Argani P., Lal P., Hutchinson B. et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J SurgPathol 2003;27(6):750–61.

43. Hes O., Comperat E.M., Rioux-Leclercq N. et al. The 2012 ISUP Vancouver and 2016 WHO classification of adult renal tumors: changes for common renal tumors. Diagnostic Histopathol 2016;22(2):41–6. DOI: 10.1016/j.mpdhp.2016.01.003.

44. Lopez-Beltran A., Kirkali Z., Montironi R. et al. Unclassified renal cell carcinoma: a report of 56 cases. BJU Int 2012;110(6):786–93. DOI: 10.1111/j.1464-410X.2012.10934.x.

45. Perrino C.M., Grignon D.J., Williamson S.R. et al. Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases. Histopathology 2018;72(2):305–19. DOI: 10.1111/his.13362.

46. Brunelli M., Gobbo S., Segala D. et al. Clear or basophilic type 1 papillary renal cell carcinoma-like cells occuring in the central fibrous scar of renal oncocytoma represent a potential diagnostic pitfall. Mod Pathol 2010;23(1S):182A.

47. Campodonico F., Carmignani G., Toncini C. Bilateral renal oncocytosis with renal failure. Arch Pathol Lab Med 2002;126(6):648–9. DOI: 10.1043/00039985(2002)126<0648:BROWRF>2.0.CO;2.

48. Hes O., Michal M., Kuroda N. et al. Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases. Arch Pathol Lab Med 2007;131(12):1782–8. DOI: 10.1043/1543-2165(2007)131[1782:VR IROI]2.0.CO;2.

49. Liu L., Qian J., Singh H. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 2007;131(8):1290–7. DOI: 10.1043/1543-2165(2007)131[1290:IAOCRC]2.0.CO;2.

50. Zhou M., Kort E., Hoekstra P. et al. Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence. Am J Surg Pathol 2009;33(1):72–80. DOI: 10.1097/PAS.0b013e3181852105.

51. Stamatiou K., Polizois K., Kollaitis G. et al. Cystic nephroma: a case report and review of the literature. Cases J 2008;1(1):267. DOI: 10.1186/1757-1626-1-267.

52. Cibas E.S., Goss G.A., Kulke M.H. et al. Malignant epithelioidangiomyolipoma (‘sarcoma ex angiomyolipoma’) of the kidney: a case report and review of the literature. Am J Surg Pathol 2001;25(1):121–6.

53. Kawaguchi K., Oda Y., Nakanishi K. et al. Malignant transformation of renal angiomyolipoma: a case report. Am J Surg Pathol 2002;26(4):523–9.

54. Tan G., Liu L., Qiu M. et al. Clinicopathologic features of renal epithelioidangiomyolipoma. Int J Clin Exp Pathol 2015;8(1):1077–80.

55. Michal M., Hes O., Nemcova J. et al. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch 2009;454(1):89–99. DOI: 10.1007/s00428-008-0697-3.

56. Jayalakshmy P.S., Jose M., Feroze M. et al. Renal angiomyoadenomatous tumour. Turk J Urol 2017;43(3):378–82. DOI: 10.5152/tud.2017.32067.